Every one of those 1 sits in a single category, health-it. ClinCapture is most often covered alongside AI-Powered Clinical Trial Build Platform, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 3.3 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about ClinCapture
Every one of those 1 sits in a single category, health-it. ClinCapture is most often covered alongside AI-Powered Clinical Trial Build Platform, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 3.3 across the same-window beat baseline. At 7, the average consequence score sits above the same-window beat average of 5.9. ClinCapture appears in 1 tracked Healthcare story from March 12, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 38 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering ClinCapture. Shared-story counts are live from our verified record — not editorial picks.
ClinCapture CEO Scott Weidley has unveiled a new AI-powered clinical trial build engine integrated into the Captivate platform. The system automates the translation of protocol specifications into digital EDC components, aiming to replace manual configuration with intelligent trial architecture.